Comment le bénéfice par action récent de MEDVF se compare-t-il aux attentes ?
Comment les revenus de Medivolve Inc MEDVF se sont-ils comportés au dernier trimestre ?
Quelle est l'estimation des revenus pour Medivolve Inc ?
Quel est le score de qualité des bénéfices pour Medivolve Inc ?
Quand Medivolve Inc publie-t-elle ses résultats ?
Quels sont les bénéfices attendus de Medivolve Inc ?
Medivolve Inc a-t-elle dépassé les attentes en matière de bénéfices ?
Statistiques clés
Clôture préc.
$0.002
Prix d'ouverture
$0.002
Plage de la journée
$0.002 - $0.002
Plage de 52 semaines
$0.0016 - $0.0079
Volume
100
Volume moyen
0
BPA (TTM)
-0.65
Rendement en dividend
--
Capitalisation boursière
$54.0K
Qu’est-ce que MEDVF ?
Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-08-04. The firm and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. The company has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.